verapamil and amyloid beta-peptides

verapamil has been researched along with amyloid beta-peptides in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawford, F; Fang, C; Mullan, M; Suo, Z2
Beyreuther, K; Masters, CL; Sáez-Valero, J; Sberna, G; Small, DH1
Hong, S; Nazer, B; Selkoe, DJ1

Other Studies

4 other study(ies) available for verapamil and amyloid beta-peptides

ArticleYear
Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity.
    Brain research, 1997, Jul-11, Volume: 762, Issue:1-2

    Topics: Amyloid beta-Peptides; Antipsychotic Agents; Aorta; Apoptosis; Calcium; Calcium Channel Blockers; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Endothelium, Vascular; Free Radicals; Humans; Necrosis; Peptide Fragments; Pimozide; Superoxide Dismutase; Superoxides; Time Factors; Verapamil

1997
The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells.
    Journal of neurochemistry, 1997, Volume: 69, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholinesterase; Amyloid beta-Peptides; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Embryonal; Diltiazem; Gene Expression Regulation, Enzymologic; Kinetics; Marine Toxins; Nifedipine; Oxocins; Peptide Fragments; Tumor Cells, Cultured; Verapamil

1997
Characteristics of the in vitro vasoactivity of beta-amyloid peptides.
    Experimental neurology, 1998, Volume: 150, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aorta; Calcimycin; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cerebral Amyloid Angiopathy; Drug Synergism; Endothelin-1; Endothelium, Vascular; Ionophores; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Verapamil

1998
LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model.
    Neurobiology of disease, 2008, Volume: 30, Issue:1

    Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Biotinylation; Blood-Brain Barrier; Calcium Channel Blockers; Cell Line, Transformed; Dogs; Endocytosis; Epithelial Cells; Hormone Antagonists; Iodine Isotopes; Low Density Lipoprotein Receptor-Related Protein-1; Mifepristone; Models, Biological; Peptide Fragments; Time Factors; Transfection; Verapamil

2008